Search results
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
The Income Investor's Dream Team: 7 Sturdy Dividend Stocks Yielding 6%
InvestorPlace· 2 days agoThe most obvious reason investors should buy high-yield dividend stocks is that they provide income....
3 Dividend Stocks You May Want To Double Down On
Benzinga via Yahoo Finance· 2 days agoSometimes, misunderstood stocks benefit investors. Savvy investors can capitalize when a stock is incorrectly perceived as weak during a recession....
Moderna's RSV vaccine for older adults approved
Axios· 6 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19
Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line
InvestorPlace· 3 days agoAs you approach retirement, it’s crucial to carefully consider your investment portfolio and make...
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 7 days agoPfizer Once-booming COVID-19 vaccine sales have plunged, dragging down Pfizer's (NYSE: PFE) overall revenue and earnings ...
TIME100 Most Influential Companies 2024: Pfizer
Time Magazine· 7 days agoFind out why Pfizer is on the list
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 6 days agoFood and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot...
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 19 hours agoThis year’s American Society of Clinical Oncology (ASCO) conference in Chicago marked a return to...